Vulcur MedTech is a medical device development company focusing on wound healing, using our VMT (VulCur MedTech) laser.
Chronic wounds are defined as wounds which refuse to heal within a period of 3 months. At this stage wounds are no longer able to heal by themselves or may take years to do so.
Available types of treatment have not changed over the past 50 years. The old fashioned techniques such as dressing application and wound cleansing only target the top layer of the wound. They fail to target the in depth bacterial biofilm which is present in and around chronic wounds.
Research has shown the existence of biofilm producing bacteria within the tissue in and around chronic wounds. These bacteria show a great resistance to antibiotics and secrete inflammatory antigrowth factors which stall the healing process. It is believed that all chronic wounds are infected with this biofilm producing bacteria.
Our VMT method of treatment uses laser pulses which penetrate inside the tissues ablating the bacteria without damaging the human cells. This helps aid the body’s natural healing process.
The VMT method makes healing of otherwise untreatable chronic wounds possible. It also reduces the time to heal while increasing patients’ quality of life.
Janus Larsen (CEO, Founder, Male) Janus founded VulCur MedTech in 2018. He has a background in microbiology and biochemistry. Janus’ professional experience covers business development and licensing, gained from over 5 years of working as a Commercial Officer at the University of Copenhagen and then as a life science and medical device independent consultant. Most recently, Janus worked as a project manager for a business consulting firm that supports pharmaceutical companies in optimizing their project management processes. Janus founded Poscogen Aps(biotech company), which was acquired by Thornico A/S in 2011.
Professor Magnus Ågren (Clinical Advisor, Male) Professor Ågren is a full professor at Bispebjerg University Hospital, having worked as a wound healing scientist in academia, in industry and in hospitals for 35 years. He has published over 100 wound healing articles in internationally renowned medical journals, acted as a scientific advisor for a number of Scandinavian and international companies in the wound healing sector, and serves on the editorial boards for a number of biomedical journals. He is also the president of the European Tissue Repair Society. Prof. Ågren provides clinical oversight for VulCur MedTech.
Claus Rehfeld (Chairman, Male) Mr. Rehfeld is a serial entrepreneur who most recently started ‘Health Innovation Institute’, a consulting company specialized in delivering healthcare innovations. Clients include Danish municipalities, Danish hospitals, South-Eastern Norway Regional Health Authority and Roche. Mr Rehfeld will play a key role in promoting FLASH-HEAL™ to healthcare authorities in the Nordic region. Claus founded Quintiles (business intelligence in healthcare), acquired by IMS Health in 2015.
Bettina Grote, Senior R&D Engineer, Novo Nordisk (Industry Advisor, Female) Ms. Grote has over 11 years of experience working as an engineer and research scientist for global medical device and pharmaceutical companies, including Coloplast, Ferring Pharmaceuticals, Radiometer Medical, Leo Pharma and Novo Nordisk. Her expertise is in design control, compliance and regulatory documentation for medical device development projects. Ms.Grote provides VulCur with oversight on Medical Device Quality Assurance.
Claus Rømer Andersen, Independent consultant, EMC & Radio Medical Devices (Technical Advisor, Male) Mr Andersen has a background in electronic engineering, with more than 10 years experience in medical device development and Quality Assurance. He is an independent consultant to medical device start-up companies. Previously, Mr Andersen worked as Head of Product Management and Devices at Leo Pharma and most recently, as Vice President at FORCE Technology, a technological consultant company. Mr Andersen provides VulCur with advice on the technical developments of FLASH-HEAL.
Emil Jacobsen, Chief Technical Officer, EyeJustRead (Technical advisor, Male) Emil has a background in artificial intelligence, image analysis and recognition software. Emil will provide advice to VulCur on software developments that will be required for FLASH-HEAL
Peter E. Andersen P.hd. Peter E. Andersons speciality is multimodal biophotonic imaging; nonlinear microscopy, optical coherence tomography including light source development, systems development and clinical/biomedical applications within dermatology, ophthalmology, and urology. Light source development for biomedical applications and ultrafast applications. Author/co-author of 125+ peer-reviewed scientific papers and book chapters, editor of one book, and 60+ conference proceedings.
Jes Broeng P.hd. Jes Broeng is a serial high-tech entrepreneur, photonics scientist, and professor at the Technical University of Denmark and is author and co-author of more than 200 publications (including Science), 1 textbook, and 18 patents(h-index = 44, +10.000 citations). Jes Broeng’s research interests include business and leadership areas of entrepreneurship, innovation and technology transfer, and scientific areas of optics, photonics and communications. He has extensive experience in applied research, early high-tech business development, IPR and licensing, and high-tech sales (US, Europe, and Asia).
Prof. Klaus Kirketerp-Møller, M.D. ,Chief Surgeon, Copenhagen Wound Healing Center, (Clinical advisor, Male) Prof. Kirketerp-Møller’s expertise covers chronic wound healing, orthopaedic infections, bacterial biofilm and diabetic foot ulcers. He provides clinical advice and oversight to VulCur.